Home/Filings/4/0001829126-23-004521
4//SEC Filing

Leider Harry L. 4

Accession 0001829126-23-004521

CIK 0001557376other

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:05 PM ET

Size

6.7 KB

Accession

0001829126-23-004521

Insider Transaction Report

Form 4
Period: 2023-06-28
Leider Harry L.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-06-29$0.01/sh+500,000$5,0001,049,450 total(indirect: See footnote)
  • Purchase

    Common Stock

    2023-06-28$0.10/sh+549,450$54,396549,450 total(indirect: See footnote)
Footnotes (1)
  • [F1]The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.

Issuer

Organicell Regenerative Medicine, Inc.

CIK 0001557376

Entity typeother

Related Parties

1
  • filerCIK 0001888273

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:05 PM ET
Size
6.7 KB